MedPath

Tongji University Tongji Hospital of(Formerly Ganquan Hospital)

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Stage IV Non-small Cell Lung Cancer
Interventions
Radiation: SBRT+TKI
Drug: TKI
First Posted Date
2018-07-23
Last Posted Date
2021-04-08
Lead Sponsor
Tongji Hospital
Target Recruit Count
74
Registration Number
NCT03595644
Locations
🇨🇳

Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma

Not Applicable
Conditions
Gallbladder Cancer
Surgery
Interventions
Procedure: Open
Procedure: Three dimensional laparoscopic
First Posted Date
2018-04-09
Last Posted Date
2018-04-09
Lead Sponsor
Tongji Hospital
Target Recruit Count
200
Registration Number
NCT03491878
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion

Not Applicable
Recruiting
Conditions
Prostate Cancer
Interventions
Procedure: Cystoprostatectomy
Radiation: external beam radiotherapy
First Posted Date
2018-03-29
Last Posted Date
2022-10-21
Lead Sponsor
Tongji Hospital
Target Recruit Count
70
Registration Number
NCT03482089
Locations
🇨🇳

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Nasogastric Tube in Pancreatic Surgery

Not Applicable
Conditions
Pancreatic Surgery
Nasogastric Tube Decompression
Interventions
Procedure: non-NGT group
Procedure: NGT group
First Posted Date
2018-03-12
Last Posted Date
2018-03-12
Lead Sponsor
Tongji Hospital
Target Recruit Count
50
Registration Number
NCT03462602
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Evaluation of Clinical and Genetic Modifiers of Long-term Survival in Heart Failure

Conditions
Heart Failure
Interventions
Other: No intervention
First Posted Date
2018-03-09
Last Posted Date
2019-04-10
Lead Sponsor
Tongji Hospital
Target Recruit Count
2500
Registration Number
NCT03461107
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

Treatment of Common Bile Duct Stones

Not Applicable
Conditions
Common Bile Duct Stone
Interventions
Procedure: LC + LCBDE + ENBD + primary closure of CBD
Procedure: ERCP technique + LC
Procedure: LC + LCBDE + primary closure of CBD
First Posted Date
2018-02-22
Last Posted Date
2018-03-01
Lead Sponsor
Tongji Hospital
Target Recruit Count
200
Registration Number
NCT03442205
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

Completed
Conditions
Non-small Cell Lung Cancer
Interventions
Procedure: Sublobar dissection
First Posted Date
2018-02-09
Last Posted Date
2018-05-21
Lead Sponsor
Tongji Hospital
Target Recruit Count
3902
Registration Number
NCT03427567
Locations
🇨🇳

China-Japan Friendship Hospital, Beijing, Beijing, China

🇨🇳

Henan cancer hospital, Zhengzhou, Henan, China

🇨🇳

Jiangsu cancer hospital, Nanjing, Jiangsu, China

and more 7 locations

Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma

Not Applicable
Conditions
Cholangiocarcinoma, Perihilar
Surgery
Interventions
Procedure: Three dimensional laparoscopic resection for pCCA
Procedure: Open resection for pCCA
First Posted Date
2017-12-26
Last Posted Date
2020-10-08
Lead Sponsor
Tongji Hospital
Target Recruit Count
30
Registration Number
NCT03383796
Locations
🇨🇳

Tongji Hospital, Wuhan, Hubei, China

A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)

Conditions
Infection
End Stage Liver Disease
Interventions
Drug: Antibiotics
First Posted Date
2017-12-06
Last Posted Date
2018-09-14
Lead Sponsor
Tongji Hospital
Target Recruit Count
2000
Registration Number
NCT03363451
Locations
🇨🇳

Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIP Study)

Conditions
Infection
End Stage Liver Disease
Spontaneous Bacterial Peritonitis
Interventions
Drug: Antibiotics
First Posted Date
2017-12-05
Last Posted Date
2018-09-13
Lead Sponsor
Tongji Hospital
Target Recruit Count
400
Registration Number
NCT03362632
Locations
🇨🇳

Department of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath